DESCRIPTION (provided by applicant): Protein misfolding, fibrillization, and aggregation have emerged as potential therapeutic targets to treat many neurodegenerative diseases.
Recent advances in the development of in vitro fibrillization assays have enabled high throughput screenings (HTS) to be used for interrogating compound libraries to identify fibrillization inhibitors.